Use of nystatin to eliminate spontaneous revertants in yeast

Journal of Bacteriology
|January 1, 1968
PubMed

Insights

Nystatin pretreatment effectively removes prototroph revertants, a common issue in suppressor mutant studies. This method significantly reduces background noise, enabling clearer observation of induced mutations.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Induction of suppressor mutants is crucial for genetic research.
  • Pre-existing revertants in cell populations can obscure studies on induced mutations.
  • Auxotrophs typically contain a minority of prototroph revertants.

Purpose of the Study:

  • To develop a method for eliminating background prototroph revertants.
  • To improve the accuracy of studies investigating induced suppressor mutations.

Main Methods:

  • Utilized nystatin as a pretreatment agent.
  • Applied nystatin under specific, optimized conditions.
  • Administered mutagen after nystatin treatment to assess induced mutation frequency.

Main Results:

  • Nystatin pretreatment significantly decreased the frequency of prototroph revertants.
  • A reduction of approximately 30-fold in prototroph frequency was observed.
  • This reduction is sufficient to study induced mutation rates near spontaneous levels.

Conclusions:

  • Nystatin pretreatment is an effective strategy to eliminate background revertants.
  • This technique enhances the study of induced mutations by reducing experimental noise.
  • The method allows for more accurate analysis of mutation induction frequencies.